Categories Consumer, Earnings

Big Lots surpasses Q1 earnings estimates; lifts FY19 earnings outlook

Community retailer Big Lots’ (NYSE: BIG) first quarter 2019 adjusted earnings of $0.92 per share topped analysts estimates $0.70, while revenue of $1.3 billion was in line with the targets. Comp store sales grew 1.5% and the company lifted its earnings outlook for fiscal 2019. Shares of Big Lots, which plunged to a new 52-week low ($25.73) on Thursday, surged more than 10% in the pre-market trading hours today.

Big Lots (BIG) Q1 2019 earnings - comp store sales trend

On a GAAP basis, Big Lots reported income of $15.5 million or $0.39 per share compared to $31.2 million or $0.74 per share in the first quarter of 2018.

For the second quarter of 2019, Big Lots expects GAAP earnings to be between $0.05 and $0.15 per share and adjusted earnings to be in the range of $0.35 to $0.45 per share. Comparable store sales growth is touted to be in the low single digit range.

The Columbus, Ohio-based firm lifted fiscal year 2019 adjusted income per share guidance to a range of $3.70 to $3.85 from the prior estimate of $3.55 to $3.75 per share. The company maintained the comp store sales growth outlook of low single digit range.

Among other retailers, Dollar General (DG) reported its quarterly earnings before the market opened yesterday, while Dollar Tree Stores (DLTR) and Costco Wholesale (COST) reported their quarterly results after the bell.

Big Lots stock, which tumbled to an eight-year low in December, had dropped 18% in the last three months and 39% in the 52 weeks.

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top